Transplantation of hematopoietic stem cells (HSCs) has been successfully developed as a
part of treatment protocols for a large number of clinical indications, and cryopreservation of …

Hematopoietic stem cell (HSC) therapy is widely used to treat a growing number of
hematological and non-hematological diseases. Cryopreservation of HSCs allows for cells …

A retrospective review of the published literature identified several hundred adverse
reactions (eg nausea, chills, cardiac arrhythmias, neurological symptoms and respiratory …

Recent studies illustrate the potential for improving the cryopreservation of stem cells.
Reduced DMSO concentrations in the cryopreservation medium, post thaw washing of cells …

Hematopoietic stem cells (HSC) can be stored for prolonged periods at cryogenic
temperatures. The techniques currently used were derived from the initial report in 1949 of …

Background aims Peripheral blood stem cells (PBSC) have become the preferred stem cell
source for autologous hematopoietic transplantation. A critical aspect of this treatment …

We report the long-term evaluation over 12 years of a simplified technique for stem-cell
cryopreservation at-80 degrees C without rate-controlled freezing and with 5%(n= 251) or …

The procedure of autologous peripheral blood stem cell transplantation (autoPBSCT)
requires cryopreservation of cells in a mixture containing dimethyl sulfoxide (DMSO). DMSO …

Background: Cryopreservation of hematopoietic cells with the rate‐controlled method is
used in the majority of centers. In recent years, there has been a trend toward the …

Background aims Infusion of stem cell autografts can be associated with adverse effects.
Necrotic normal leukocytes, cytokines or intracellular mediators released from leukocytes …